$CAH

CARDINAL HEALTH INC

CIK:0000721371|SEC Filings

Consolidated Statements of Earnings/(Loss) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenue	$ 254,248	$ 222,578	$ 226,827
Cost of products sold	244,474	214,410	219,413
Gross margin	9,774	8,168	7,414
Operating expenses:
Distribution, selling, general, and administrative expenses	6,132	5,382	5,000
Restructuring and employee severance	106	88	175
Amortization and other acquisition-related costs	469	464	284
Acquisition-related cash and share-based compensation costs [Line Items]	287	126	0
Impairments and (gain)/loss on disposal of assets, net	177	18	634
Litigation (recoveries)/charges, net	(10)	(185)	78
Operating earnings	2,613	2,275	1,243
Other (income)/expense, net	(31)	(41)	(9)
Interest expense, net	348	215	51
Equity Method Investment, Other-than-Temporary Impairment	122	0	0
Earnings before income taxes	2,174	2,101	1,201
Income Tax Expense (Benefit)	469	532	348
Net earnings	1,705	1,569	853
Less: Net (earnings)/loss attributable to noncontrolling interests	9	(8)	(1)
Net earnings attributable to Cardinal Health, Inc.	$ 1,714	$ 1,561	$ 852
Earnings per common share attributable to Cardinal Health, Inc.
Basic (in dollars per share)	$ 7.27	$ 6.48	$ 3.48
Diluted (in dollars per share)	$ 7.23	$ 6.45	$ 3.45
Weighted-average number of common shares outstanding:
Basic (in shares)	236	241	245
Diluted (in shares)	237	242	247

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net earnings	$ 1,705	$ 1,569	$ 853
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	956	790	710
Impairments and (gain)/loss on sale of other investments, net	21	3	2
Equity Method Investment, Other-than-Temporary Impairment	122	0	0
Impairments and (gain)/loss on disposal of assets, net	177	18	634
Share-based compensation	367	244	121
Provision for/(benefit from) deferred income taxes	91	243	(104)
Provision for bad debts	74	53	36
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:
Increase in trade receivables	(408)	(833)	(996)
(Increase)/decrease in inventories	(488)	(1,816)	1,115
Increase in accounts payable	3,463	2,732	1,824
Repurchases of liability-classified units	(45)	(19)	0
Other accrued liabilities and operating items, net	(861)	(587)	(433)
Net cash provided by operating activities	5,174	2,397	3,762
Cash flows from investing activities:
Acquisition of subsidiaries, net of cash acquired	(1,991)	(5,250)	(1,190)
Additions to property and equipment	(649)	(547)	(511)
Proceeds from disposal of property and equipment	31	3	12
Proceeds from investments	41	15	1
Payments for (Proceeds from) Hedge, Investing Activities	(13)	2	34
Purchase of short-term time deposits	0	0	(550)
Proceeds from short-term investment in time deposit	0	200	350
Other investing items, net	(3)	(16)	5
Net cash used in investing activities	(2,584)	(5,593)	(1,849)
Cash flows from financing activities:
Proceeds from long-term obligations, net of issuance costs	990	3,669	1,139
Purchase of noncontrolling interests	11	12	0
Reduction of long-term obligations	(653)	(445)	(783)
Net tax proceeds/(withholding) from share-based compensation	(79)	(13)	46
Dividends on common shares	(491)	(494)	(499)
Purchase of treasury shares	(1,358)	(765)	(750)
Net cash provided by/(used in) financing activities	(1,602)	1,940	(847)
Effect of exchange rates changes on cash and equivalents	(6)	(3)	(9)
Net increase/(decrease) in cash and equivalents	982	(1,259)	1,057
Cash and equivalents at beginning of period	3,874	5,133	4,076
Cash and equivalents at end of period	4,856	3,874	5,133
Supplemental Information:
Cash payments for interest	406	315	214
Net cash payments for income taxes	$ 338	$ 444	$ 191

Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
Current assets:
Cash and equivalents	$ 4,856	$ 3,874
Trade receivables, net	13,815	13,242
Inventories, net	17,297	16,831
Prepaid expenses and other	2,764	2,414
Assets held for sale	21	12
Total current assets	38,753	36,373
Property and equipment, net	3,031	2,858
Goodwill and other intangibles, net	13,631	12,177
Other assets	1,884	1,714
Assets, Total	57,299	53,122
Current liabilities:
Accounts payable	38,283	34,713
Current portion of long-term obligations and other short-term borrowings	1,882	550
Other accrued liabilities	3,739	3,634
Total current liabilities	43,904	38,897
Long-term obligations, less current portion	7,004	7,977
Deferred income taxes and other liabilities	9,115	8,882
Preferred shares, without par value:
Authorized—500 thousand shares, Issued—none	0	0
Common shares, without par value:
Authorized—755 million shares, Issued— 271 million shares at June 30, 2026 and 2025	2,887	2,956
Retained earnings	2,009	783
Common shares in treasury, at cost: 38 million shares and 32 million shares at June 30, 2026 and 2025, respectively	(7,614)	(6,365)	$ (5,677)	$ (4,911)
Accumulated other comprehensive loss	(165)	(155)
Total Cardinal Health, Inc. shareholders' deficit	(2,883)	(2,781)
Noncontrolling interests	159	147
Total shareholders’ deficit	(2,724)	(2,634)	$ (3,212)	$ (2,957)
Total liabilities and shareholders’ deficit	$ 57,299	$ 53,122